Literature DB >> 24556467

The effect of hydrotherapy treatment on gait characteristics of hereditary spastic paraparesis patients.

Yanxin Zhang1, Richard Roxburgh2, Liang Huang1, John Parsons3, T Claire Davies4.   

Abstract

BACKGROUND: Hereditary spastic paraparesis (HSP) is a group of neurological disorders characterised by slowly progressive increasing muscle tone, predominantly in the lower limbs, with relatively preserved power. This leads to progressive difficulties in motor control and walking.
OBJECTIVE: The purpose of this study was to evaluate the effectiveness of hydrotherapy treatment when used as a means to increase locomotor function in individuals with late onset HSP. This paper discusses the analysis of the effect on gait characteristics.
METHODS: Nine people with HSP were asked to participate in pre- and post-hydrotherapy gait analyses. Ground reaction force and motion trajectories were recorded and used to calculate spatiotemporal gait parameters, joint angles and moments.
RESULTS: The normalised joint kinematics and kinetics profile revealed that the biomechanics of people with HSP were similar to that of controls for most of the joints, but with lower range of motion. Walking speed increased significantly (11%) after the course of hydrotherapy. Though part of this was achieved through increased ROM there was also a further increase in hip internal rotation and in peak hip extension moment.
CONCLUSIONS: Although participants had increased walking speed and step length, it appears that hydrotherapy increases the ability to perform compensatory strategies rather than resulting in a more typical kinematic and kinetic approach.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomechanics; Hereditary spastic paraparesis; Hereditary spastic paraplegia; Hydrotherapy

Mesh:

Year:  2014        PMID: 24556467     DOI: 10.1016/j.gaitpost.2014.01.010

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  7 in total

1.  Assessment of waveform similarity in clinical gait data: the linear fit method.

Authors:  M Iosa; A Cereatti; A Merlo; I Campanini; S Paolucci; A Cappozzo
Journal:  Biomed Res Int       Date:  2014-07-13       Impact factor: 3.411

2.  Gait Patterns in Patients with Hereditary Spastic Paraparesis.

Authors:  Mariano Serrao; Martina Rinaldi; Alberto Ranavolo; Francesco Lacquaniti; Giovanni Martino; Luca Leonardi; Carmela Conte; Tiwana Varrecchia; Francesco Draicchio; Gianluca Coppola; Carlo Casali; Francesco Pierelli
Journal:  PLoS One       Date:  2016-10-12       Impact factor: 3.240

3.  Management of Hereditary Spastic Paraplegia: A Systematic Review of the Literature.

Authors:  Marta Bellofatto; Giovanna De Michele; Aniello Iovino; Alessandro Filla; Filippo M Santorelli
Journal:  Front Neurol       Date:  2019-01-22       Impact factor: 4.003

4.  Improving gait adaptability in patients with hereditary spastic paraplegia (Move-HSP): study protocol for a randomized controlled trial.

Authors:  Lotte van de Venis; Bart P C van de Warrenburg; Vivian Weerdesteyn; Bas J H van Lith; Alexander C H Geurts; Jorik Nonnekes
Journal:  Trials       Date:  2021-01-07       Impact factor: 2.279

5.  Hereditary Spastic Paraplegia in Koreans: Clinical Characteristics and Factors Influencing the Disease Severity.

Authors:  Jong Geol Do; Byoung Joon Kim; Nam-Soon Kim; Duk Hyun Sung
Journal:  J Clin Neurol       Date:  2022-02-14       Impact factor: 2.566

Review 6.  The Puzzle of Hereditary Spastic Paraplegia: From Epidemiology to Treatment.

Authors:  Arun Meyyazhagan; Haripriya Kuchi Bhotla; Manikantan Pappuswamy; Antonio Orlacchio
Journal:  Int J Mol Sci       Date:  2022-07-11       Impact factor: 6.208

7.  Progression of Functional Gait in Hereditary Spastic Paraplegias.

Authors:  Diana Maria Cubillos-Arcila; Gustavo Dariva Machado; Lauren Sehnem; Daniela Burguêz; Ana Paula Janner Zanardi; Valéria Feijó Martins; Leonardo Alexandre Peyré-Tartaruga; Jonas Alex Morales Saute
Journal:  Cerebellum       Date:  2021-07-09       Impact factor: 3.847

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.